Moderate Dietary Salt Restriction Increases Vascular and Systemic Insulin Resistance

作者: Ross D Feldman , Nancy D Schmidt

DOI: 10.1016/S0895-7061(99)00016-3

关键词: SodiumVasoconstrictionMedicineInsulin resistanceVasodilationDiet therapyLow sodiumLow sodium dietEndocrinologyInsulinInternal medicine

摘要: Our recent studies have indicated that severe salt restriction aggravates vascular insulin resistance in younger normotensive and hypertensive subjects. However, whether the extent of dietary commonly advocated adversely affects is unknown. To determine moderate might affect systemic sensitivity to insulin, we studied eight subjects after 1 week a normal sodium diet (235 mEq/day) (75 meq/day). Systemic as assessed by fasting plasma glucose-to-insulin ratio was aggravated (normal sodium: 1.2 +/- 0.1 mmol/mIU; low 0.6 0.1, P < .05). Salt significantly reduced maximal insulin-mediated vasodilation 51% 5% maximum nitroglycerin-mediated response; 28% 6%, .01). In contrast, no alterations nor phenylephrine-mediated vasoconstriction were noted. These demonstrate both resistance. This impairment vasodilating effect could be factor attenuating blood pressure lowering diet.

参考文章(28)
B Göbel, A Overlack, J Diehl, N Hittel, K Kraft, K O Stumpe, M Ruppert, R Kolloch, Short-term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults. Journal of Molecular Medicine. ,vol. 69, pp. 51- 57 ,(1991)
A D Baron, G Brechtel-Hook, A Johnson, D Hardin, Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension. ,vol. 21, pp. 129- 135 ,(1993) , 10.1161/01.HYP.21.2.129
DavidH. Frankel, Dr Elders' return to Arkansas The Lancet. ,vol. 345, pp. 120- ,(1995) , 10.1016/S0140-6736(95)90083-7
M.H. Duncan, B.M. Singh, P.H. Wise, G. Carter, J. Alaghband-Zadeh, A simple measure of insulin resistance The Lancet. ,vol. 346, pp. 120- 121 ,(1995) , 10.1016/S0140-6736(95)92143-5
R D Feldman, I M Hramiak, D T Finegood, M T Behme, Parallel regulation of the local vascular and systemic metabolic effects of insulin. The Journal of Clinical Endocrinology & Metabolism. ,vol. 80, pp. 1556- 1559 ,(1995) , 10.1210/JCEM.80.5.7744999
R R Wing, C H Bunker, L H Kuller, K A Matthews, Insulin, body mass index, and cardiovascular risk factors in premenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 9, pp. 479- 484 ,(1989) , 10.1161/01.ATV.9.4.479
R.D. Feldman, G.S. Bierbrier, Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. The Lancet. ,vol. 342, pp. 707- 709 ,(1993) , 10.1016/0140-6736(93)91708-T
H O Steinberg, G Brechtel, A Johnson, N Fineberg, A D Baron, Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. Journal of Clinical Investigation. ,vol. 94, pp. 1172- 1179 ,(1994) , 10.1172/JCI117433